These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25707623)

  • 21. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.
    Ruiz G; Andrey JL; Puerto JL; Escobar MA; Romero SP; Aranda R; Pedrosa MJ; Gomez F
    Int J Cardiol; 2016 Nov; 222():594-602. PubMed ID: 27513657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction.
    Farasat SM; Bolger DT; Shetty V; Menachery EP; Gerstenblith G; Kasper EK; Najjar SS
    Am J Cardiol; 2010 Jan; 105(2):229-34. PubMed ID: 20102924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
    Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
    Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
    Dekleva M; Düngen HD; Gelbrich G; Incrot S; Suzic Lazic J; Pavlovic Kleut M; Tahirovic E; Waagstein F
    Aging Clin Exp Res; 2012 Dec; 24(6):675-81. PubMed ID: 23147689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of beta-blockers for heart failure in patients with diabetes mellitus.
    Giles TD
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):32-7. PubMed ID: 19667606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.
    Mascarenhas J; Lourenço P; Lopes R; Azevedo A; Bettencourt P
    Am Heart J; 2008 Mar; 155(3):521-5. PubMed ID: 18294490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
    Galatius S; Gustafsson F; Atar D; Hildebrandt PR
    Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.
    Metra M; Torp-Pedersen C; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Dei Cas L; Spark P; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2007 Sep; 9(9):901-9. PubMed ID: 17581778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blocker treatment of stable heart failure in primary care.
    Verdú Rotellar JM; Barroso A; Bernáldez MJ; Domíngueza M; Pie M; Sancho F; Simó M; Domingo M
    Rev Esp Cardiol; 2009 Oct; 62(10):1141-8. PubMed ID: 19793520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
    Fonseca V; Sharma PP; Shah M; Deedwania P
    Curr Med Res Opin; 2011 Apr; 27(4):799-807. PubMed ID: 21306286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discharge use of carvedilol is associated with higher survival in Japanese elderly patients with heart failure regardless of left ventricular ejection fraction.
    Yanagihara K; Kinugasa Y; Sugihara S; Hirai M; Yamada K; Ishida K; Kato M; Yamamoto K
    J Cardiovasc Pharmacol; 2013 Nov; 62(5):485-90. PubMed ID: 24072178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.